Analysts predict that LHC Group, Inc. (NASDAQ:LHCG) will report earnings of $1.03 per share for the current quarter, according to Zacks Investment Research. Five analysts have issued estimates for LHC Group’s earnings, with the highest EPS estimate coming in at $1.12 and the lowest estimate coming in at $0.99. LHC Group reported earnings of $0.62 per share in the same quarter last year, which indicates a positive year-over-year growth rate of 66.1%. The firm is expected to announce its next earnings report on Wednesday, February 27th.
According to Zacks, analysts expect that LHC Group will report full-year earnings of $3.53 per share for the current financial year, with EPS estimates ranging from $3.49 to $3.54. For the next financial year, analysts forecast that the company will report earnings of $4.17 per share, with EPS estimates ranging from $4.14 to $4.20. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side research firms that cover LHC Group.
LHC Group (NASDAQ:LHCG) last posted its quarterly earnings results on Wednesday, October 31st. The health services provider reported $0.95 EPS for the quarter, hitting the consensus estimate of $0.95. LHC Group had a net margin of 3.85% and a return on equity of 8.23%. The company had revenue of $507.00 million during the quarter, compared to analysts’ expectations of $515.03 million. During the same quarter in the previous year, the business posted $0.64 EPS. The firm’s revenue was up 88.0% on a year-over-year basis.
NASDAQ LHCG traded up $0.59 on Thursday, hitting $105.73. 188,600 shares of the stock were exchanged, compared to its average volume of 245,986. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.17. LHC Group has a fifty-two week low of $58.65 and a fifty-two week high of $109.33. The stock has a market capitalization of $3.33 billion, a PE ratio of 43.69, a price-to-earnings-growth ratio of 1.51 and a beta of 0.88.
In other news, CEO Keith G. Myers sold 6,790 shares of the company’s stock in a transaction on Monday, January 7th. The shares were sold at an average price of $95.01, for a total value of $645,117.90. Following the completion of the transaction, the chief executive officer now owns 155,475 shares in the company, valued at approximately $14,771,679.75. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, SVP Jeff Reibel sold 5,239 shares of the company’s stock in a transaction on Tuesday, December 4th. The shares were sold at an average price of $105.26, for a total transaction of $551,457.14. The disclosure for this sale can be found here. In the last 90 days, insiders sold 241,821 shares of company stock valued at $23,703,540. Company insiders own 6.80% of the company’s stock.
Large investors have recently modified their holdings of the stock. Private Capital Group LLC boosted its stake in LHC Group by 60.2% during the 4th quarter. Private Capital Group LLC now owns 897 shares of the health services provider’s stock worth $84,000 after purchasing an additional 337 shares during the period. C M Bidwell & Associates Ltd. acquired a new stake in LHC Group during the 3rd quarter worth $117,000. Quantamental Technologies LLC acquired a new stake in LHC Group during the 4th quarter worth $182,000. Almanack Investment Partners LLC. acquired a new stake in LHC Group during the 3rd quarter worth $193,000. Finally, First Citizens Bank & Trust Co. acquired a new stake in LHC Group during the 3rd quarter worth $204,000. Hedge funds and other institutional investors own 86.79% of the company’s stock.
About LHC Group
LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.
Recommended Story: What are the Benefits of Index Funds?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.